Literature DB >> 9753545

TOM1p, a yeast hect-domain protein which mediates transcriptional regulation through the ADA/SAGA coactivator complexes.

A Saleh1, M Collart, J A Martens, J Genereaux, S Allard, J Cote, C J Brandl.   

Abstract

The hect-domain has been characterized as a conserved feature of a group of E3 ubiquitin ligases. Here we show that the yeast hect-domain protein TOM1p regulates transcriptional activation through effects on the ADA transcriptional coactivator proteins. Null mutations of tom1 result in similar defects in transcription from ADH2 and HIS3 promoters, and enhanced transcription from the GAL10 promoter as do null mutations in ngg1/ada3. Strains with disruptions of both ngg1 and tom1 have the same phenotype as strains with a disruption of only ngg1 implying that these genes are acting through the same pathway. In the absence of TOM1p, the normal associations of the ADA proteins with SPT3p and the TATA-binding protein are reduced. The action of TOM1p is most likely mediated through ubiquitination since mutation of Cys3235 to Ala, corresponding residues of which are required for thioester bond formation with ubiquitin in other hect-domain proteins, results in similar changes in transcription as the null mutation. A direct role for TOM1p in regulation of ADA-associated proteins is further supported by the finding that SPT7p is ubiquitinated in a TOM1p-dependent fashion and that TOM1p coimmunoprecipitates with the ADA proteins. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753545     DOI: 10.1006/jmbi.1998.2036

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Genes encoding ribosomal proteins Rps0A/B of Saccharomyces cerevisiae interact with TOM1 mutants defective in ribosome synthesis.

Authors:  A L Tabb; T Utsugi; C R Wooten-Kee; T Sasaki; S A Edling; W Gump; Y Kikuchi; S R Ellis
Journal:  Genetics       Date:  2001-03       Impact factor: 4.562

2.  Old dogs and new tricks: meeting on mechanisms of eukaryotic transcription.

Authors:  Elena Ejkova; William P Tansey
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

Review 3.  Ubiquitin and proteasomes in transcription.

Authors:  Fuqiang Geng; Sabine Wenzel; William P Tansey
Journal:  Annu Rev Biochem       Date:  2012-03-08       Impact factor: 23.643

4.  Identification and quantitative expression analysis of genes that are differentially expressed during conidial germination in Pyrenophora teres.

Authors:  M Dilger; F G Felsenstein; G Schwarz
Journal:  Mol Genet Genomics       Date:  2003-08-23       Impact factor: 3.291

5.  Characterization of E3Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones.

Authors:  Zhiqian Liu; Rose Oughtred; Simon S Wing
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 6.  Multi-tasking on chromatin with the SAGA coactivator complexes.

Authors:  Jeremy A Daniel; Patrick A Grant
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

7.  The Hect domain E3 ligase Tom1 and the F-box protein Dia2 control Cdc6 degradation in G1 phase.

Authors:  Dong-Hwan Kim; Wei Zhang; Deanna M Koepp
Journal:  J Biol Chem       Date:  2012-11-05       Impact factor: 5.157

8.  Analysis of Spt7 function in the Saccharomyces cerevisiae SAGA coactivator complex.

Authors:  Pei-Yun Jenny Wu; Fred Winston
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8.

Authors:  Karl W Henry; Anastasia Wyce; Wan-Sheng Lo; Laura J Duggan; N C Tolga Emre; Cheng-Fu Kao; Lorraine Pillus; Ali Shilatifard; Mary Ann Osley; Shelley L Berger
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

10.  Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis.

Authors:  Rakesh Kumar Singh; Marie-Helene Miquel Kabbaj; Johanna Paik; Akash Gunjan
Journal:  Nat Cell Biol       Date:  2009-07-05       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.